Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.06%
median of 853 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Rein Therapeutics Inc.
Market Cap
$22.88M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$23.26M
Net Profit Margin
-6.64%
TTM Avg
-71.34%
3Y Avg
-193.00%
5Y Avg
-1292.64%
Market Cap
$22.11M
Net Profit Margin
-24.76%
TTM Avg
-22.59%
3Y Avg
-21.34%
5Y Avg
-47.79%
Market Cap
$21.80M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$24.07M
Net Profit Margin
3967.77%
TTM Avg
1344.00%
3Y Avg
468.01%
5Y Avg
273.57%
Market Cap
$24.13M
Net Profit Margin
0.00%
TTM Avg
-481.06%
3Y Avg
-1941.22%
5Y Avg
-2233.39%
Market Cap
$21.40M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$24.94M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rein Therapeutics Inc. (RNTX) | $22.88M | 0.00% | 0.00% | 0.00% | 0.00% |
| LeonaBio, Inc. (LONA)vs › | $22.54M | 0.00% | 0.00% | 0.00% | 0.00% |
| TherapeuticsMD, Inc. (TXMD)vs › | $23.26M | -6.64% | -71.34% | -193.00% | -1292.64% |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.11M | -24.76% | -22.59% | -21.34% | -47.79% |
| Modular Medical, Inc. (MODD)vs › | $21.80M | 0.00% | 0.00% | 0.00% | 0.00% |
| Kyntra Bio, Inc. (KYNB)vs › | $24.07M | 3967.77% | 1344.00% | 468.01% | 273.57% |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.13M | 0.00% | -481.06% | -1941.22% | -2233.39% |
| Quantum BioPharma Ltd. (QNTM)vs › | $21.40M | 0.00% | 0.00% | 0.00% | 0.00% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.94M | 0.00% | 0.00% | 0.00% | 0.00% |
| InspireMD, Inc. (NSPR)vs › | $25.29M | -355.17% | -499.98% | -419.63% | -405.79% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
